Mechanism of Action and In Vitro Activity of 1′,3′-Dioxolanylpurine Nucleoside Analogues against Sensitive and Drug-Resistant Human Immunodeficiency Virus Type 1 Variants

Por Gu, Zhengxian, Wainberg, Mark A., Nguyen-Ba, Nghe, L’Heureux, Lucille, de Muys, Jean-Marc, Bowlin, Terry L., Rando, Robert F.
Publicado em 1999

Antiviral Properties of a Series of 1,6-Naphthyridine and 7,8-Dihydroisoquinoline Derivatives Exhibiting Potent Activity against Human Cytomegalovirus

Por Bedard, Jean, May, Suzanne, L'Heureux, Lucille, Stamminger, Thomas, Copsey, Alice, Drach, John, Huffman, John, Chan, Laval, Jin, Haolun, Rando, Robert F.
Publicado em 2000

Discovery of Thienoimidazole-Based HCV NS5A Genotype 1a and 1b Inhibitors

Por Giroux, Simon, Xu, Jinwang, Reddy, T. Jagadeeswar, Morris, Mark, Cottrell, Kevin M., Cadilhac, Caroline, Henderson, James A., Nicolas, Oliver, Bilimoria, Darius, Denis, Francois, Mani, Nagraj, Ewing, Nigel, Shawgo, Rebecca, L’Heureux, Lucille, Selliah, Subajini, Chan, Laval, Chauret, Nathalie, Berlioz-Seux, Francoise, Namchuk, Mark N., Grillot, Anne-Laure, Bennani, Youssef L., Das, Sanjoy K., Maxwell, John P.
Publicado em 2013